On-chip 3D potency assay for prediction of clinical outcomes for cell therapy candidates for osteoarthritis
Cytotherapies involving bone marrow- or adipose tissue-derived mesenchymal cells are actively pursued to treat diverse inflammatory and immunological disorders, including myocardial infarcts, osteoarthritis, autoimmune disorders, and diabetic and gastrointestinal wounds.